Atypical Presentation of Flatbush Diabetes During a Febrile Illness: A Case Report and Review of Literature

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2024 Dec 5

PMID 39634998

Authors

Asif Dabeer Jafri

Srikant K Dhar

Tanmaya Brahmadarshini Bhuyan

Promod K Tudu

Mareya Zeenat

Kayenaat Rizvi

Affiliations

Soon will be listed here.

Abstract

Flatbush diabetes is a significant clinical condition that is gaining recognition on a global scale. Although it's commonly believed that individuals who exhibit symptoms of diabetic ketoacidosis (DKA) have type 1 diabetes and need to take insulin continuously for the rest of their lives, this isn't always the case. Understanding the differences between the natural histories of type 1 and 2 diabetes mellitus (DM) and Flatbush diabetes will aid in early diagnosis and appropriate management. We present a very unusual case of Flatbush diabetes in a young male who presents with recurrent episodes of DKA during febrile illness. Only a few such cases have been documented in the medical literature, despite recent advancements in diabetes research.

References

Yamada K, Nonaka K . Diabetic ketoacidosis in young obese Japanese men. Diabetes Care. 1996; 19(6):671. DOI: 10.2337/diacare.19.6.671a. View

Mirel R, Ginsberg-Fellner F, Horwitz D, Rayfield E . C-Peptide reserve in insulin-dependent diabetes. Comparative responses to glucose, glucagon and tolbutamide. Diabetologia. 1980; 19(3):183-8. DOI: 10.1007/BF00275266. View

Mauvais-Jarvis F, Sobngwi E, Porcher R, Riveline J, Kevorkian J, Vaisse C . Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance. Diabetes. 2004; 53(3):645-53. DOI: 10.2337/diabetes.53.3.645. View

Banerji M, Chaiken R, Huey H, Tuomi T, Norin A, Mackay I . GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Flatbush diabetes. Diabetes. 1994; 43(6):741-5. DOI: 10.2337/diab.43.6.741. View

Umpierrez G, Clark W, Steen M . Sulfonylurea treatment prevents recurrence of hyperglycemia in obese African-American patients with a history of hyperglycemic crises. Diabetes Care. 1997; 20(4):479-83. DOI: 10.2337/diacare.20.4.479. View

Owen K . Monogenic diabetes in adults: what are the new developments?. Curr Opin Genet Dev. 2018; 50:103-110. DOI: 10.1016/j.gde.2018.04.006. View

Umpierrez G, Kelly J, Navarrete J, Casals M, Kitabchi A . Hyperglycemic crises in urban blacks. Arch Intern Med. 1997; 157(6):669-75. View

Maldonado M, Hampe C, Gaur L, DAmico S, Iyer D, Hammerle L . Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and beta-cell functional classification, prospective analysis, and clinical outcomes. J Clin Endocrinol Metab. 2003; 88(11):5090-8. DOI: 10.1210/jc.2003-030180. View

Mauvais-Jarvis F, Smith S, Le May C, Leal S, Gautier J, Molokhia M . PAX4 gene variations predispose to ketosis-prone diabetes. Hum Mol Genet. 2004; 13(24):3151-9. PMC: 6145178. DOI: 10.1093/hmg/ddh341. View

10.

Vaibhav A, Mathai M, Gorman S . Atypical diabetes in children: ketosis-prone type 2 diabetes. BMJ Case Rep. 2013; 2013. PMC: 3604177. DOI: 10.1136/bcr-2012-007704. View

11.

Sobngwi E, Vexiau P, Levy V, Lepage V, Mauvais-Jarvis F, Leblanc H . Metabolic and immunogenetic prediction of long-term insulin remission in African patients with atypical diabetes. Diabet Med. 2002; 19(10):832-5. DOI: 10.1046/j.1464-5491.2002.00802.x. View

12.

Yahaya T, Ufuoma S . Genetics and Pathophysiology of Maturity-onset Diabetes of the Young (MODY): A Review of Current Trends. Oman Med J. 2020; 35(3):e126. PMC: 7254248. DOI: 10.5001/omj.2020.44. View

13.

Umpierrez G, Casals M, Gebhart S, Mixon P, Clark W, Phillips L . Diabetic ketoacidosis in obese African-Americans. Diabetes. 1995; 44(7):790-5. DOI: 10.2337/diab.44.7.790. View

14.

Umpierrez G, Smiley D, Gosmanov A, Thomason D . Ketosis-prone type 2 diabetes: effect of hyperglycemia on beta-cell function and skeletal muscle insulin signaling. Endocr Pract. 2007; 13(3):283-90. DOI: 10.4158/EP.13.3.283. View

15.

Umpierrez G, Smiley D, Kitabchi A . Narrative review: ketosis-prone type 2 diabetes mellitus. Ann Intern Med. 2006; 144(5):350-7. DOI: 10.7326/0003-4819-144-5-200603070-00011. View

16.

Jha S, Waghdhare S, Siddiqui S, Srivastava K, Bhargava A . First identification of Flatbush diabetes in patients of Indian origin. Diabetes Care. 2015; 38(10):e164-5. DOI: 10.2337/dc15-1209. View

17.

Verge C, Stenger D, Bonifacio E, Colman P, Pilcher C, Bingley P . Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. Diabetes. 1998; 47(12):1857-66. DOI: 10.2337/diabetes.47.12.1857. View

18.

Westphal S . The occurrence of diabetic ketoacidosis in non-insulin-dependent diabetes and newly diagnosed diabetic adults. Am J Med. 1996; 101(1):19-24. DOI: 10.1016/s0002-9343(96)00076-9. View

19.

Winter W, Maclaren N, Riley W, CLARKE D, KAPPY M, Spillar R . Maturity-onset diabetes of youth in black Americans. N Engl J Med. 1987; 316(6):285-91. DOI: 10.1056/NEJM198702053160601. View